Scientific advisers to the Centers for Disease Control and Prevention met on Wednesday to begin to decide which Americans should get booster shots of the Pfizer-BioNTech coronavirus vaccine — and when.
The committee’s discussions followed a dramatic exchange at the Food and Drug Administration on Friday, when advisers overwhelmingly rejected a proposal to offer Pfizer booster shots to all Americans over age 16, but then voted unanimously in favor of third doses for some high-risk people and those older than age 65.
privacy policy | terms of use | contact us | advertise | pharma blogs | facebook | twitter
Copyright © 2025,